Virus

New Insights into Virus Evasion Tactics

David Alvaro, Ph.D.

Pharma's Almanac

Research

Researchers Discover Potential Cause for Alzheimer’s Disease

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CRISPR

CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next

Nigel Walker

Nice Insight

Clinical Data

Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719

Nice Insight

FDA Approval

AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment

Cynthia A. Challener, Ph.D.

Pharma's Almanac

GMP

State-of-the-Art Biologics Manufacturing in an Unexpected Location

Vladas Algirdas Bumelis

Northway Biotechpharma

Next-Generation Drug Development

Challenges for Next-Generation Biological Therapeutics in Discovery and Development

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

Fill-Finish Services

Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

Andrea Baiocchi

Avara Pharmaceutical Services

Drug Discovery

TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date

Guy Tiene

Nice Insight

Discovery

A New Landscape: M&A in the Discovery & Research Sector

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

Biologics

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Samsung Biologics

Innovation

Single-Pill, HIV-1 Combination Therapy Approved

Nice Insight

Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

Nice Insight

FDA Approval

Advanced Follicular Lymphoma Treatment Approved

Nice Insight

Gene Editing

Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems

Nice Insight

Non-Opioid

SiteOne Therapeutics Garners US Department of Defense Award

Emilie Branch

Pharma's Almanac

Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

Nice Insight